chg7 Jun 2012 09:14
For Tempus in the Times, defence contractor Chemring is not a buy. It trades on just six times earnings and yields 6% so the maths look good but, short of a takeover bid, Tempus doesn't believe the shares are going anywhere and the sale of its marine flares brand, Pains Wessex, looks like a bad decision. Leave